Question 1

Am I eligible for this trial based on my current health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

Question 2

How does etelcalcetide compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of etelcalcetide?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for treatment if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

Question 5

What monitoring will be involved during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder clinical trial (NCT01414114). Contact the study team or your healthcare provider for specific answers.

What this study is about